FEIM vs. EYPT, AEHR, SENS, ALNT, QTRX, QSI, NAUT, KEQU, AKYA, and SEER
Should you be buying Frequency Electronics stock or one of its competitors? The main competitors of Frequency Electronics include EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Senseonics (SENS), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Akoya Biosciences (AKYA), and Seer (SEER). These companies are all part of the "measuring and control equipment" industry.
Frequency Electronics vs.
Frequency Electronics (NASDAQ:FEIM) and EyePoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.
EyePoint Pharmaceuticals has a consensus target price of $26.63, suggesting a potential upside of 255.95%. Given EyePoint Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe EyePoint Pharmaceuticals is more favorable than Frequency Electronics.
In the previous week, EyePoint Pharmaceuticals had 4 more articles in the media than Frequency Electronics. MarketBeat recorded 5 mentions for EyePoint Pharmaceuticals and 1 mentions for Frequency Electronics. EyePoint Pharmaceuticals' average media sentiment score of 0.29 beat Frequency Electronics' score of 0.27 indicating that EyePoint Pharmaceuticals is being referred to more favorably in the news media.
58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 99.4% of EyePoint Pharmaceuticals shares are held by institutional investors. 26.1% of Frequency Electronics shares are held by insiders. Comparatively, 4.7% of EyePoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Frequency Electronics has higher revenue and earnings than EyePoint Pharmaceuticals. EyePoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
Frequency Electronics has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500. Comparatively, EyePoint Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500.
EyePoint Pharmaceuticals received 379 more outperform votes than Frequency Electronics when rated by MarketBeat users. Likewise, 70.24% of users gave EyePoint Pharmaceuticals an outperform vote while only 60.14% of users gave Frequency Electronics an outperform vote.
Frequency Electronics has a net margin of 13.02% compared to EyePoint Pharmaceuticals' net margin of -226.57%. Frequency Electronics' return on equity of 21.49% beat EyePoint Pharmaceuticals' return on equity.
Summary
EyePoint Pharmaceuticals beats Frequency Electronics on 10 of the 18 factors compared between the two stocks.
Get Frequency Electronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Frequency Electronics Competitors List
Related Companies and Tools
This page (NASDAQ:FEIM) was last updated on 1/20/2025 by MarketBeat.com Staff
